This site is intended for US audiences.

• Important Safety Information
• Prescribing Information
• Patient Information
• For HCPs

TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 2 years of age.